Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119189973 | 11918997 | 3 | F | 201403 | 20160816 | 20160115 | 20160912 | PER | US-JNJFOC-20151213889 | JANSSEN | 71.70 | YR | E | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119189973 | 11918997 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 15 AND 20 MG | Y | N | UNKNOWN | 0 | TABLET | ||||||
119189973 | 11918997 | 2 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 22406 | TABLET | |||||||
119189973 | 11918997 | 3 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | TABLET | ||||||||
119189973 | 11918997 | 4 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | TABLET | ||||||||
119189973 | 11918997 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | Y | 0 | 75 | MG | TABLET | |||||||
119189973 | 11918997 | 6 | SS | NITROSTAT | NITROGLYCERIN | 1 | Sublingual | U | 0 | .4 | MG | TABLET | |||||||
119189973 | 11918997 | 7 | C | LYRICA | PREGABALIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
119189973 | 11918997 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
119189973 | 11918997 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
119189973 | 11918997 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
119189973 | 11918997 | 11 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119189973 | 11918997 | 1 | Pulmonary embolism |
119189973 | 11918997 | 2 | Pulmonary embolism |
119189973 | 11918997 | 3 | Pulmonary embolism |
119189973 | 11918997 | 4 | Deep vein thrombosis |
119189973 | 11918997 | 5 | Product used for unknown indication |
119189973 | 11918997 | 6 | Product used for unknown indication |
119189973 | 11918997 | 7 | Product used for unknown indication |
119189973 | 11918997 | 8 | Product used for unknown indication |
119189973 | 11918997 | 9 | Product used for unknown indication |
119189973 | 11918997 | 10 | Product used for unknown indication |
119189973 | 11918997 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119189973 | 11918997 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119189973 | 11918997 | Epistaxis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119189973 | 11918997 | 1 | 20140327 | 20140406 | 0 | |
119189973 | 11918997 | 2 | 201312 | 2014 | 0 |